AI Insights · Timothy · January 2023
Top 5 Superhero Games on iOS in South Africa Q4 2022
In Q4 2022, superhero games on iOS in South Africa showed varied performance trends in downloads, revenue, and active users. Notable apps include [Marvel Contest of Champions](https://app.sensortower.com/overview/896112560?country=US), [DRAGON BALL Z DOKKAN BATTLE](https://app.sensortower.com/overview/951627425?country=US), and [Injustice 2](https://app.sensortower.com/overview/1109008423?country=US).
In Q4 2022, superhero games on iOS in South Africa exhibited diverse trends in downloads, revenue, and active users. Here’s an overview of the performance of the top 5 superhero games based on data from Sensor Tower.
Marvel Contest of Champions
Weekly revenue for Marvel Contest of Champions fluctuated throughout the quarter, peaking at around $7.5K in the week of November 21. Weekly downloads increased significantly in November, reaching 195 in the week of November 28. Active users showed a consistent upward trend, culminating at 549 in the last week of December.
DRAGON BALL Z DOKKAN BATTLE
DRAGON BALL Z DOKKAN BATTLE saw a revenue peak of approximately $2.5K in the final week of December. Downloads varied, with a high of 263 in the week of October 10. Active users increased steadily, reaching 373 by mid-December.
MARVEL Strike Force: Squad RPG
For MARVEL Strike Force: Squad RPG, revenue peaked at $1K in the week of December 19. Downloads were highest in mid-November at 305. Active users spiked in the same period, reaching 248.
Injustice 2
Injustice 2 experienced steady revenue growth, peaking at $540 in the week of December 12. Downloads reached a high of 179 in the same week. Active users also saw a rise, hitting 291 in mid-December.
X-HERO
X-HERO showed a consistent increase in revenue, peaking at $603 in the week of December 19. Downloads were relatively stable, with a slight peak at 78 in mid-October. Active users increased steadily, reaching 258 by the end of December.
For more detailed insights and data, visit Sensor Tower.